journal article Feb 24, 2021

Pharmacist‐led intervention on chronic pain management: A systematic review and meta‐analysis

View at Publisher Save 10.1111/bcp.14745
Abstract
AimsPharmacists have been contributing to the management of chronic pain, ensuring the quality use of medicine. However, there is diversity in the interventions provided by pharmacists and their impact.MethodsSix electronic databases were searched from inception until June 2020 for articles published in English examining the intervention provided by the pharmacist in chronic pain management. Studies investigating the impact of pharmacist intervention individually or multidisciplinary teams including pharmacists for chronic pain management were included.ResultsFourteen studies (2365 participants) were included in the current review. Six studies were randomized controlled trials while the remainder were observational studies in which pharmacists provided intervention individually or in collaboration with other healthcare professionals. Medication review was the most common intervention provided by the pharmacist. The pooled analysis found that pharmacist‐led interventions reduced the pain intensity (−0.22; 95% confidence interval [CI]: −0.35 to −0.09; moderate certainty) among participants with chronic pain. Opiate stewardship provided by pharmacists was effective; however, mixed results were noted on the impact of the intervention on physical functioning, anxiety, depression and quality of life. Pharmacist intervention was more expensive than treatment as usual.ConclusionsPharmacists contribute substantially to chronic pain management, ensuring the quality use of medicine, resulting in reduced pain intensity. Further studies with rigorous design are needed to measure the impact of pharmacist‐provided intervention individually or in a multidisciplinary team on the economic benefit and other health outcomes.
Topics

No keywords indexed for this article. Browse by subject →

References
39
[1]
Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11)

Rolf-Detlef Treede, Winfried Rief, Antonia Barke et al.

Pain 10.1097/j.pain.0000000000001384
[4]
The Economic Costs of Pain in the United States

Darrell J. Gaskin, Patrick Richard

The Journal of Pain 10.1016/j.jpain.2012.03.009
[12]
RoB 2: a revised tool for assessing risk of bias in randomised trials

Jonathan A C Sterne, Jelena Savović, Matthew J Page et al.

BMJ 10.1136/bmj.l4898
[13]
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

Jonathan AC Sterne, Miguel A Hernán, Barnaby C Reeves et al.

BMJ 10.1136/bmj.i4919
[14]
(2020)
[29]
Aryani FMY "Chronic care model in primary care: can it improve health‐related quality of life?" Integr Pharm Res Pract (2016)
[39]
NICE.Chronic pain in over 16s: assessment and management. NICE draft guideline August 2020.